|
Sumitomo Chemical Company, Limited is a diversified chemical and pharmaceutical group operating through five main business segments. The Agro & Life Solutions segment manufactures and sells pesticides, fertilizers, agricultural materials, household and public health insecticides, and feed additives. The ICT & Mobility Solutions segment produces optical products, semiconductor process materials, compound semiconductor materials, touch sensor panels, high-purity aluminum, engineering plastics, and battery components. The Advanced Medical Solutions segment provides contract development and manufacturing services for low-molecule pharmaceuticals, oligonucleotides, and regenerative cell therapies. The Essential & Green Materials segment manufactures synthetic resins, synthetic fiber raw materials, industrial chemicals, metacrylate, and synthetic rubber. The Sumitomo Pharma segment develops and sells low-molecule pharmaceuticals. The group also engages in power and steam supply, transportation, and warehousing. Key subsidiaries include Sumitomo Biochemical Company LLC, Sumitomo Chemical Brazil, Sumitomo Chemical Chile, Sumitomo Chemical India, Toyoka Fine Chemical, Sumika Semiconductor Materials Texas, SSLM, Sumitomo Chemical America, Sumika Polymers America, Sumitomo Chemical Asia, Hiroe Chemical, Nippon Singapore Petrochemical, PCS Private Limited, The Polyolefin Company, Lavig Refining and Petrochemical Company, Sumitomo Pharma, Sumitomo Pharma America, Sumitomo Pharma Suisse, and Euroviant Sciences. The company was founded in 1913. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Chemicals | Homepage sumitomo-chem.co.jp |
| Sector Basic Materials | IR page sumitomo-chem.co.jp/ir | |
|
Tags
agrochemicals, semiconductor materials, pharmaceuticals, contract manufacturing, synthetic resins, optical products, battery components, industrial chemicals, synthetic rubber, metacrylate, Sumitomo Biochemical Company LLC, Biorant Bioscience LLC, Biorant U.S.A. LLC, Sumitomo Chemical Brazil Industria Quimica S.A., Sumitomo Chemical Chile S.A., Sumitomo Chemical India Limited, Toyoka Fine Chemical, Sumika Semiconductor Materials Texas Incorporated, SSLM, Sumitomo Chemical Electronic Materials Technology (Wuxi) Co. Ltd., Sumitomo Chemical Technology Co. Ltd., Tanaka Chemical Research Institute, Toka Chemical Industry, Hiroe Chemical, Nippon Singapore Petrochemical, PCS Private Limited, The Polyolefin Company (Singapore) Private Limited, Lavig Refining and Petrochemical Company, Sumitomo Chemical America Incorporated, Sumika Polymers America Corporation, Sumitomo Chemical Asia Private Limited, Sumitomo Pharma, Sumitomo Pharma America Incorporated, Sumitomo Pharma Suisse GmbH, Euroviant Sciences GmbH, Sumitomo Seika, Biondo, CFP-TOMO
|
Press page sumitomo-chem.co.jp/english/ir/news |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 948.563B |
| Market cap (USD) | $ 5.943B |
| P/E | 9.06 |
| PEG | 0.09 |
| P/BV | 0.64 |
| P/S | 0.39 |
| P/OCF | 3.89 |
| P/FCF | 8.38 |
| Dividend yield | 2.4% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 5.3% |
| ROI | 2.6% |
| ROIC | 6.3% |
| Profit margin | 2.6% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | 105.9% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -5.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.329T | 2.606T | 2.447T | 2.895T | 2.765T | 2.287T | 2.226T | 2.319T | 2.217T | 1.954T | 2.102T | 2.377T | 2.244T | 1.952T |
| Net profit | 60.947B | 38.591B | -311.838B | 6.987B | 162.13B | 46.043B | 30.926B | 117.992B | 126.039B | 85.482B | 81.451B | 52.192B | 36.977B | -51.076B |
| Free cash flow | 113.199B | 101.302B | -209.722B | -29.46B | 52.192B | 261.76B | -10.336B | 44.48B | — | 55.691B | 171.407B | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 499.43 | 361.41 | 338.62 | 444.94 | 562.05 | 572.99 | 321.07 | 515.08 | 620.14 | 622.03 | 508.96 | 617.95 | 380.95 | — |
| Price performance 12m | 0.38 | 0.07 | -0.24 | -0.21 | -0.02 | 0.78 | -0.38 | -0.17 | -0 | 0.22 | -0.18 | 0.62 | — | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 455B | 531B | 550B | 570B | 653B | 720B | 603B | 620B | 594B | 609B |
| ↳ YoY growth | +9.7% | +3.7% | +3.7% | +14.4% | +10.4% | -16.3% | +2.8% | -4.2% | +2.5% | |
| ↳ 5y CAGR | +2.6% | +2.4% | +0.8% | -1.4% | ||||||
| Borrowings, current (JPY) | 302B | 289B | 257B | 467B | 250B | 261B | 397B | 586B | 253B | 241B |
| Borrowings, non-current (JPY) | 574B | 553B | 583B | 838B | 1.1T | 1.09T | 1.06T | 978B | 1.03T | 910B |
| Bonds payable (JPY) | 278B | — | — | — | — | — | — | — | — | — |
| Cash and deposits (JPY) | 193B | 232B | 202B | 181B | 361B | 365B | 306B | 217B | 210B | 209B |
| Intangible assets (JPY) | 358B | 233B | 217B | 466B | 450B | 471B | 404B | 273B | 239B | 225B |
| Net debt (borrowings + leases - cash) (JPY) | 714B | 610B | 638B | 1.12T | 990B | 985B | 1.16T | 1.35T | 1.08T | 943B |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 187B | 288B | 208B | 106B | 374B | 172B | 112B | -51.3B | 233B | 235B |
| Purchases of property, plant and equipment (JPY) | -132B | — | -164B | -116B | -113B | -120B | -141B | -158B | -132B | -122B |
| Change in receivables (cash effect) (JPY) | -32.2B | -24.6B | -26.6B | -10.9B | -22.4B | -19.5B | 134B | 34.8B | -22B | -3.62B |
| Change in inventories (cash effect) (JPY) | 2.45B | -55.6B | -35.6B | -11.7B | 12.6B | -98.2B | -79.9B | 78.6B | 56.5B | 38.6B |
| Change in payables (cash effect) (JPY) | 31.2B | 73.6B | -18.7B | -22B | 48.3B | -39.2B | -63.6B | -32.3B | -6.11B | -71.9B |
| Dividends paid (cash effect) (JPY) | -21.3B | -27.8B | -37.6B | -36B | -19.6B | -31.1B | -42.5B | -19.6B | -9.87B | -19.7B |
| Share buybacks (cash effect) (JPY) | -51M | — | — | — | — | — | — | — | — | — |
| Interest paid (cash effect) (JPY) | -10.7B | -10.5B | -10.9B | -12.7B | -15.9B | -15.4B | -21.8B | -28.1B | -27.5B | -29.8B |
| Income taxes paid (cash effect) (JPY) | -65.1B | -28.7B | -50.2B | -48.7B | -54.4B | -68.3B | -65.5B | -48.3B | -10.1B | -27.4B |
| Operating cash flow before change in receivables (JPY) | 220B | 318B | 235B | 117B | 397B | 191B | -22.9B | -86.1B | 255B | 238B |
| Free cash flow (OCF - PPE - intangibles) (JPY) | 55.7B | — | 44.5B | -10.3B | 262B | 52.2B | -29.5B | -210B | 101B | 113B |
| Income detail | ||||||||||
| Research and development expense (JPY) | 158B | 162B | 164B | 174B | 179B | 175B | 196B | 184B | 145B | 145B |
| ↳ 5y CAGR | +3.8% | +2.4% | -3.6% | -4.1% | ||||||
| Total comprehensive income (JPY) | 105B | 162B | 148B | -17.4B | 136B | 255B | 65.6B | -302B | -54.6B | 188B |
| Comprehensive income to owners (JPY) | 88.3B | 142B | 110B | -39.1B | 109B | 230B | 84.1B | -187B | -54B | 120B |
| Segments | ||||||||||
| Advanced Medical Solutions · Segment revenue (JPY) | — | — | — | — | — | — | — | 73.4B | 72.5B | 72.4B |
| ↳ YoY growth | -1.2% | -0.2% | ||||||||
| Advanced Medical Solutions · Segment operating income (JPY) | — | — | — | — | — | — | — | 6.06B | 3.97B | 2.82B |
| Agro And Life Solutions · Segment revenue (JPY) | — | — | — | — | — | — | — | 518B | 541B | 520B |
| ↳ YoY growth | +4.6% | -3.9% | ||||||||
| Agro And Life Solutions · Segment operating income (JPY) | — | — | — | — | — | — | — | 26.4B | 55B | 56.3B |
| Energy And Functional Materials · Segment revenue (JPY) | — | 257B | 291B | 265B | 255B | 329B | 360B | 317B | — | — |
| ↳ YoY growth | +12.9% | -9.0% | -3.8% | +29.2% | +9.5% | -11.8% | ||||
| Energy And Functional Materials · Segment operating income (JPY) | — | 19.2B | 23B | 20.3B | 20.3B | 20.1B | 15.2B | 7.83B | — | — |
| Essential And Green Materials · Segment revenue (JPY) | — | — | — | — | — | — | — | 891B | 904B | 683B |
| ↳ YoY growth | +1.4% | -24.4% | ||||||||
| Essential And Green Materials · Segment operating income (JPY) | — | — | — | — | — | — | — | -89.1B | -58.5B | 14.4B |
| Essential Chemicals And Plastics · Segment revenue (JPY) | — | — | — | — | — | 848B | 859B | 779B | — | — |
| ↳ YoY growth | +1.3% | -9.2% | ||||||||
| Essential Chemicals And Plastics · Segment operating income (JPY) | — | — | — | — | — | 53.5B | -34.2B | -90.7B | — | — |
| Health And Agriculture Related · Segment revenue (JPY) | — | 343B | 344B | 349B | 428B | 481B | 604B | 552B | — | — |
| ↳ YoY growth | +0.1% | +1.6% | +22.5% | +12.3% | +25.6% | -8.6% | ||||
| Health And Agriculture Related · Segment operating income (JPY) | — | 44B | 19.7B | 2.08B | 31.5B | 42.3B | 57.3B | 30.9B | — | — |
| ICT And Mobility Solutions · Segment revenue (JPY) | — | — | — | — | — | — | — | 591B | 610B | 575B |
| ↳ YoY growth | +3.2% | -5.8% | ||||||||
| ICT And Mobility Solutions · Segment operating income (JPY) | — | — | — | — | — | — | — | 50B | 70.6B | 53B |
| Information Electronic Chemistry · Segment revenue (JPY) | — | 370B | 398B | 406B | 432B | 474B | 432B | 415B | — | — |
| ↳ YoY growth | +7.6% | +2.0% | +6.5% | +9.7% | -9.0% | -4.0% | ||||
| Information Electronic Chemistry · Segment operating income (JPY) | — | 12.3B | 26.2B | 25.1B | 39.7B | 57.8B | 47.6B | 44B | — | — |
| Medical Products · Segment revenue (JPY) | — | 500B | 492B | 516B | 546B | 592B | 585B | 343B | — | — |
| ↳ YoY growth | -1.6% | +4.8% | +5.9% | +8.3% | -1.2% | -41.4% | ||||
| Medical Products · Segment operating income (JPY) | — | 94.8B | 80.8B | 75.3B | 71.7B | 61.7B | 16.2B | -133B | — | — |
| Petrochemistry · Segment revenue (JPY) | — | 681B | 764B | 663B | 594B | 848B | — | — | — | — |
| ↳ YoY growth | +12.2% | -13.2% | -10.4% | +42.8% | ||||||
| Petrochemistry · Segment operating income (JPY) | — | 94.6B | 61.6B | 14.5B | -12B | 53.5B | — | — | — | — |
| Sumitomo Pharma · Segment revenue (JPY) | — | — | — | — | — | — | — | 314B | 399B | 453B |
| ↳ YoY growth | +26.9% | +13.7% | ||||||||
| Sumitomo Pharma · Segment operating income (JPY) | — | — | — | — | — | — | — | -126B | 35.3B | 108B |
| Reported | Jun 21, 2018 | Jun 21, 2019 | Jun 21, 2019 | Jun 24, 2020 | Jun 23, 2021 | Jun 21, 2023 | Jun 21, 2023 | Jun 20, 2025 | Jun 20, 2025 | Jun 22, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| Jun 26, 2026 | Acquired | Acquired Koei Chemical Company, Limited (EDINET code E00837). Its filings from before the deal are on its own company page, not shown here. |
| Dec 26, 2025 | Acquired | Acquired Tanaka Chemical Corporation (EDINET code E01050). Its filings from before the deal are on its own company page, not shown here. |
ETFs Holding Sumitomo Chemical Company, Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVIV | 0.12% | 817,300 | $ 2.583M | Nov 16, 2026 |
| DXIV | 0.08% | 55,800 | $ 181.638K | Nov 12, 2026 |
| AVDE | 0.06% | 3,858,700 | $ 12.197M | Nov 16, 2026 |
| NTSI | 0.05% | 80,500 | $ 254.341K | Jun 30, 2026 |
| DFIV | 0.05% | 3,386,899 | $ 11.025M | Nov 12, 2026 |
| DFIC | 0.04% | 2,116,600 | $ 6.89M | Nov 12, 2026 |
| DFSI | 0.03% | 123,683 | $ 402.608K | Nov 12, 2026 |
| DFAX | 0.03% | 943,700 | $ 3.072M | Nov 12, 2026 |
| DFAI | 0.02% | 1,382,400 | $ 4.5M | Nov 12, 2026 |
| DIHP | 0.00% | 41,600 | $ 135.415K | Nov 12, 2026 |









